Tyenne
Concentrate for solution for infusion
Compare
|
EU/1/23/1754/001-006
Authorised: 15/09/2023
Fresenius Kabi Deutschland GmbH
|
SPC
PIL
IPAR
EdM
|
Tyenne
Solution for injection in pre-filled syringe
Compare
|
EU/1/23/1754/007-009
Authorised: 15/09/2023
Fresenius Kabi Deutschland GmbH
|
SPC
PIL
IPAR
EdM
|
Tyenne
Solution for injection in pre-filled pen
Compare
|
EU/1/23/1754/010-012
Authorised: 15/09/2023
Fresenius Kabi Deutschland GmbH
|
SPC
PIL
IPAR
EdM
|
Tysabri
Concentrate for solution for infusion
Compare
|
EU/1/06/346/001
Biogen Netherlands B.V.
|
SPC
PIL
IPAR
EdM
|
Tysabri
Solution for injection
Compare
|
EU/1/06/346/002
Authorised: 26/03/2021
Biogen Netherlands B.V.
|
SPC
PIL
IPAR
EdM
|
Tyvense 20mg Capsules, hard
Capsule, hard
Compare
|
PA23211/005/001
Authorised: 31/07/2015
Takeda Pharmaceuticals International AG Ireland Branch
|
SPC
PIL
EdM
|
Tyvense 30 mg Capsules, Hard
Capsule, hard
Compare
|
PA23211/005/002
Authorised: 08/02/2013
Takeda Pharmaceuticals International AG Ireland Branch
|
SPC
PIL
EdM
|
Tyvense 40mg Capsules, hard
Capsule, hard
Compare
|
PA23211/005/003
Authorised: 31/07/2015
Takeda Pharmaceuticals International AG Ireland Branch
|
SPC
PIL
EdM
|
Tyvense 50 mg Capsules, Hard
Capsule, hard
Compare
|
PA23211/005/004
Authorised: 08/02/2013
Takeda Pharmaceuticals International AG Ireland Branch
|
SPC
PIL
EdM
|
Tyvense 60mg Capsules, hard
Capsule, hard
Compare
|
PA23211/005/005
Authorised: 31/07/2015
Takeda Pharmaceuticals International AG Ireland Branch
|
SPC
PIL
EdM
|
Tyvense 70 mg Capsules, Hard
Capsule, hard
Compare
|
PA23211/005/006
Authorised: 08/02/2013
Takeda Pharmaceuticals International AG Ireland Branch
|
SPC
PIL
EdM
|
Ultomiris
Concentrate for solution for infusion
Compare
|
EU/1/19/1371/001
Authorised: 02/07/2019
Alexion Europe SAS
|
SPC
PIL
IPAR
EdM
|
Ultomiris
Concentrate for solution for infusion
Compare
|
EU/1/19/1371/002
Authorised: 02/07/2019
Alexion Europe S.A.S.
|
SPC
PIL
IPAR
EdM
|
Ultomiris
Concentrate for solution for infusion
Compare
|
EU/1/19/1371/003
Authorised: 02/07/2019
Alexion Europe S.A.S.
|
SPC
PIL
IPAR
EdM
|
Ultomiris
Solution for injection
Compare
|
EU/1/19/1371/004
Authorised: 31/05/2023
Alexion Europe S.A.S.
|
SPC
PIL
IPAR
EdM
|
Uptravi
Film-coated tablet
Compare
|
EU/1/15/1083/001-003
Authorised: 12/05/2016
Janssen-Cilag International NV
|
SPC
PIL
IPAR
EdM
|
Uptravi
Film-coated tablet
Compare
|
EU/1/15/1083/004
Janssen-Cilag International NV
|
SPC
PIL
IPAR
EdM
|
Uptravi
Film-coated tablet
Compare
|
EU/1/15/1083/005
Janssen-Cilag International NV
|
SPC
PIL
IPAR
EdM
|
Uptravi
Film-coated tablet
Compare
|
EU/1/15/1083/006
Janssen-Cilag International NV
|
SPC
PIL
IPAR
EdM
|
Uptravi
Film-coated tablet
Compare
|
EU/1/15/1083/007
Janssen-Cilag International NV
|
SPC
PIL
IPAR
EdM
|